Treating separation anxiety requires behavioral modification and medication, but which drug should you choose?

has received U.S. Food and Drug Administration (FDA) approval for its Abbreviated New Drug Application (ANDA) for Norepinephrine Bitartrate Injection USP, the company announced today. The shares ...

Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...

Biocon’s share price rose 5.5% after USFDA approved JOBEVNE, a biosimilar cancer drug. This marks the company’s seventh USFDA ...

Animal studies could lead to blood tests that could guide doctors in better matching drugs to patients based on immune system ...

A: Almost a decade ago, the FDA approved two new drugs to lower LDL ... It is a serotonin-norepinephrine reuptake inhibitor (SNRI). When I took it for two years, my gut motility eventually shut ...

A week after reporting a successful phase 3 trial of Sunosi (solriamfetol) in patients with attention-deficit/hyperactivity ...

Transcend also saw significant improvements on secondary endpoints that assessed the rate of response, remission and loss of PTSD diagnosis. The biotech said 60.7% of participants lost their PTSD ...

Medical conditions can limit which weight loss pills work safely for you. For example, you should avoid phentermine if you ...

Biocon posted a net profit of Rs 659.7 crore, nearly three times higher than Rs 101.4 crore posted in the corresponding ...

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy ... rights to Jazz Pharma's dual-acting dopamine and norepinephrine reuptake inhibitor Sunosi (solriamfetol ...

The companies struck the deal believing Axsome was better equipped to develop the dopamine and norepinephrine reuptake ... the company gained an FDA approval for migraine treatment Symbravo ...